Delivery Order SPE2DB24D8003-SPE2DB25FJTSW

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $4,178.40 firm fixed-price delivery order, identified as SPE2DB24FKYZG, is for the supply of 4,565,632,881 units of Methylphenidate ER 27 mg tablets in 100-count bottles. This order is part of a larger Indefinite Delivery Contract (IDC), SPE2DB24D8001,...
This is a $6,968.09 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Methylphenidate ER 27 mg tablets. This award is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a wide range of pharmaceutical products, medical supplies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of DEXMETHYLPHENIDATE ER 5 MG CAP 100S. The contract has a firm fixed price of $1,343.71 and an ultimate completion date of October 29, 2024. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC, part of the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $7,937.66 firm fixed-price contract is for the supply of 4,564,042,715 units of the pharmaceutical product Methylphenidate ER 27 mg tablets with an ultimate completion date of March 22, 2024. No set-aside was used for this award. Dakota Drug, Inc. has over two decades of experience as a prime contractor to the federal government,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Concerta ER 54 mg tablets. The contract, valued at $3,485.12, has a firm fixed-price delivery order type and an ultimate completion date of October 17, 2024. This award is not associated with any set-aside program. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as...
This federal contract award, identified as SPE2DB24D8003|SPE2DB25FJTPE, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,060.46 Firm Fixed Price delivery order is for the supply of 4566825798 CONCERTA ER 27 MG TABLET 100S and does not have a set-aside designation. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a significant single-award Indefinite Delivery Contract (IDC) valued...
This is a $11,364.25 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the supply of METHYLPHENIDATE ER 54 MG TAB 100S and does not have a set-aside designation. Dakota Drug, Inc. is an experienced prime contractor that has provided a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support the medical supply chain...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,121.74 firm fixed-price delivery order, under contract SPE2DB24D8001, provides the U.S. Armed Forces with Concerta ER 27 mg tablets. The single-award Indefinite Delivery Contract (IDC), valued at $999,999,999.00, allows Dakota Drug, Inc. to supply a range of pharmaceutical products, medical supplies, and healthcare...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract valued at $7,836.12 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of 4,564,544,485 units of methylphenidate extended-release 27 mg tablets. The contract has an ultimate completion date of May 9, 2024 and is not set aside. Dakota Drug, Inc. is an experienced prime contractor to the DLA, providing a wide range of pharmaceutical products, medical...
This federal contract award, identified as SPE2DB24D8003|SPE2DB25FJTRD, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order with a firm fixed price, valued at $5,948.93, for the delivery of CONCERTA ER 18 MG TABLET 100S. The contract has an ultimate completion date of January 22, 2025. Dakota Drug, Inc. is a key supplier for the DLA's Troop Support Medical division, providing a wide range of...
  • SPE2DB24D8003
    Indefinite Delivery Contract
  • SPE2DB24D8003-SPE2DB25FJTSW
    Delivery Order

This federal contract award, identified as SPE2DB24D8003|SPE2DB25FJTSW, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,716.06 firm fixed-price delivery order is for the supply of 4567090744 METHYLPHENIDATE ER 27 MG TAB 100S. This contract has an ultimate completion date of January 30, 2025.

The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc., identified as SPE2DB24D8001, which has a potential value of $999,999,999.00. This IDC is part of the DLA Troop Support Medical's ECAT Generation V Program and allows the company to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The IDC has a performance period extending through December 31, 2025.

This contract award does not have a set-aside designation, indicating that it was competed on an unrestricted basis.

Generated 5/4/25, 1:04 AM